Premier Biomedical (Premier Biomedical) EV-to-EBIT : 114.29 (As of May. 02, 2024)

Premier Biomedical EV-to-EBIT Chart

Premier Biomedical Annual Data
	Trend	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19
EV-to-EBIT		Get a 7-Day Free Trial				-1.40	-0.99	-0.62	-1.41	-

Premier Biomedical Quarterly Data
	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19
EV-to-EBIT	Get a 7-Day Free Trial															-1.41	-0.50	-0.34	-	-

Competitive Comparison of Premier Biomedical's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Premier Biomedical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Premier Biomedical's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Premier Biomedical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Premier Biomedical's EV-to-EBIT falls into.

Premier Biomedical EV-to-EBIT Calculation

Premier Biomedical's EV-to-EBIT for today is calculated as:

Premier Biomedical's current Enterprise Value is $1.60 Mil.
Premier Biomedical's EBIT for the trailing twelve months (TTM) ended in Dec. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Premier Biomedical  (OTCPK:BIEI) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Premier Biomedical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2019 is calculated as:

Premier Biomedical's Enterprise Value for the quarter that ended in Dec. 2019 was $0.00 Mil.
Premier Biomedical's EBIT for the trailing twelve months (TTM) ended in Dec. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Premier Biomedical EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Premier Biomedical's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Premier Biomedical (Premier Biomedical) Business Description